XP Chemistries

XP Chemistries Equity

The The Equity of XP Chemistries (XPC.ST) as of Oct 16, 2026 is 36.94 M SEK. In the previous year, The Equity was 21.56 M SEK — a change of 71.30% (higher).

Equity

36.94 MSEK

YoY

71.30%

Last updated:

In 2025, XP Chemistries's equity was 36.94 M SEK, a 71.30% increase from the 21.56 M SEK equity in the previous year.

The XP Chemistries Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
4.57 M SEK
Jan 1, 2021
31.30 M SEK
Jan 1, 2022
29.07 M SEK
Jan 1, 2023
25.69 M SEK
Jan 1, 2024
21.56 M SEK
Jan 1, 2025
36.94 M SEK
The XP Chemistries Equity history
YEAREquityYoY
36.94 MSEK+71.30%
21.56 MSEK-16.05%
25.69 MSEK-11.63%
29.07 MSEK-7.13%
31.30 MSEK+584.56%
4.57 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

XP Chemistries Stock analysis

What does XP Chemistries do? XP Chemistries AB is a Swedish biotechnology enterprise headquartered in Sundsvall, located within the Västernorrland county. The company operates within the broader materials sector, specifically focusing on the chemicals industry. Its primary business activity centers on biotechnology research and experimental development, aiming to advance sustainable chemical production methods. XP Chemistries AB made its public debut on the stock market on October 29, 2021, under the ticker symbol XPC.ST and the ISIN SE0016787279. This initial public offering marked a significant milestone for the firm, allowing it to access capital markets to further its research and development initiatives. The company’s strategic focus is heavily invested in the creation and utilization of sustainable, nature-inspired technologies. A core component of its operational philosophy involves the development of optimal combinations of catalytic processes. These advanced catalytic systems are designed to facilitate the production of bio-based chemicals, offering an environmentally friendly alternative to traditional petrochemical methods. By leveraging these innovative approaches, XP Chemistries AB seeks to reduce the ecological footprint of chemical manufacturing while maintaining high efficiency and quality standards. The firm has secured an international patent portfolio that protects its proprietary technologies. These patents cover the unique nature-inspired solutions and catalytic combinations that form the backbone of its product development pipeline. The emphasis on sustainability and bio-based solutions aligns with global trends toward greener industrial practices and circular economy principles. Through its research efforts, the company aims to provide scalable and economically viable alternatives for the production of essential chemical compounds. The headquarters in Sundsvall serves as the central hub for its scientific and administrative operations, supporting its mission to drive innovation in the biotechnology and chemical sectors. The company’s website, https://sv.xpchemistries.com/, provides additional information regarding its ongoing projects and technological advancements. As a publicly traded entity, XP Chemistries AB is subject to regulatory oversight and reporting requirements, ensuring transparency for its shareholders and stakeholders. The firm continues to explore new avenues for applying its patented technologies to various applications within the chemical industry, striving to establish itself as a leader in sustainable chemical production. XP Chemistries is one of the most popular companies on Eulerpool.

Equity Details

Analyzing XP Chemistries's Equity

XP Chemistries's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding XP Chemistries's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating XP Chemistries's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

XP Chemistries's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in XP Chemistries’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about XP Chemistries stock

The Equity of XP Chemistries is 36.94 M SEK in 2025.

The Equity of XP Chemistries changed from 21.56 M SEK to 36.94 M SEK, representing a 71.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity XP Chemistries since 2006 – with annual values, charts, and detailed analysis.

The Equity's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's XP Chemistries historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — XP Chemistries

All Key Metrics — XP Chemistries